"neuroendocrinal" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "neuro",
        "3": "endocrinal"
      },
      "expansion": "neuro- + endocrinal",
      "name": "prefix"
    }
  ],
  "etymology_text": "From neuro- + endocrinal.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "neuroendocrinal (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with neuro-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 25, Yogesh Kumar et al., “Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response”, in BMC Medical Genomics, volume 8, →DOI:",
          "text": "Of the thirty patients, five were diagnosed for adenocarcinoma of the stomach; five for glioma including three with glioblastoma and two with astroglioma; five for acute myeloid leukemia; five for primary hepatocellular carcinoma; five for lung cancer including two with pulmonary squamous-cell carcinoma, two with pulmonary adenocarcinoma and one with pulmonary neuroendocrinal carcinoma; and five for lung-to-brain metastatic adenocarcinoma.",
          "type": "quote"
        }
      ],
      "glosses": [
        "neuroendocrine"
      ],
      "id": "en-neuroendocrinal-en-adj-zGpYvhFw",
      "links": [
        [
          "neuroendocrine",
          "neuroendocrine"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "neuroendocrinal"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "neuro",
        "3": "endocrinal"
      },
      "expansion": "neuro- + endocrinal",
      "name": "prefix"
    }
  ],
  "etymology_text": "From neuro- + endocrinal.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "neuroendocrinal (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with neuro-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "Pages with 1 entry"
      ],
      "examples": [
        {
          "ref": "2015 July 25, Yogesh Kumar et al., “Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response”, in BMC Medical Genomics, volume 8, →DOI:",
          "text": "Of the thirty patients, five were diagnosed for adenocarcinoma of the stomach; five for glioma including three with glioblastoma and two with astroglioma; five for acute myeloid leukemia; five for primary hepatocellular carcinoma; five for lung cancer including two with pulmonary squamous-cell carcinoma, two with pulmonary adenocarcinoma and one with pulmonary neuroendocrinal carcinoma; and five for lung-to-brain metastatic adenocarcinoma.",
          "type": "quote"
        }
      ],
      "glosses": [
        "neuroendocrine"
      ],
      "links": [
        [
          "neuroendocrine",
          "neuroendocrine"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "neuroendocrinal"
}